In the present study, integrative multiomics analysis identified six candidate genes, CTHRC1, TWF2, COL6A3, SLC38A5, IFI44, and OASL, associated with RCC progression and therapeutic resistance. The gene discussed is CTHRC1; the disease is renal cell carcinoma.